CN101600703A - 二螺四噁烷化合物及其在治疗疟疾和/或癌症中的应用 - Google Patents

二螺四噁烷化合物及其在治疗疟疾和/或癌症中的应用 Download PDF

Info

Publication number
CN101600703A
CN101600703A CNA2007800440866A CN200780044086A CN101600703A CN 101600703 A CN101600703 A CN 101600703A CN A2007800440866 A CNA2007800440866 A CN A2007800440866A CN 200780044086 A CN200780044086 A CN 200780044086A CN 101600703 A CN101600703 A CN 101600703A
Authority
CN
China
Prior art keywords
compound
unsubstituted
replacement
cdcl
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2007800440866A
Other languages
English (en)
Chinese (zh)
Inventor
理查德·阿梅乌
保罗·迈克尔·奥内尔
安德鲁·斯塔胡尔斯基
杰马·埃利斯
斯蒂芬·安德鲁·沃德
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Liverpool School of Tropical Medicine
Original Assignee
Liverpool School of Tropical Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Liverpool School of Tropical Medicine filed Critical Liverpool School of Tropical Medicine
Publication of CN101600703A publication Critical patent/CN101600703A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D323/00Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms
    • C07D323/04Six-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
CNA2007800440866A 2006-09-30 2007-10-01 二螺四噁烷化合物及其在治疗疟疾和/或癌症中的应用 Pending CN101600703A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0619333.8A GB0619333D0 (en) 2006-09-30 2006-09-30 Dispiro tetraoxane compounds
GB0619333.8 2006-09-30

Publications (1)

Publication Number Publication Date
CN101600703A true CN101600703A (zh) 2009-12-09

Family

ID=37434997

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2007800440866A Pending CN101600703A (zh) 2006-09-30 2007-10-01 二螺四噁烷化合物及其在治疗疟疾和/或癌症中的应用

Country Status (7)

Country Link
US (2) US20100113436A1 (enExample)
EP (2) EP2091935A2 (enExample)
JP (1) JP2010505759A (enExample)
CN (1) CN101600703A (enExample)
CA (1) CA2665339A1 (enExample)
GB (1) GB0619333D0 (enExample)
WO (1) WO2008038030A2 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110452212A (zh) * 2019-07-30 2019-11-15 浙江大学 一种11-十一内酯类化合物和己内酯类化合物的制备方法

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0904935D0 (en) 2009-03-23 2009-05-06 Liverpool School Tropical Medicine Dispiro tetraoxane compounds
US9975854B2 (en) 2014-05-06 2018-05-22 Purdue Pharma L.P. Benzomorphan analogs and use thereof
WO2020240266A1 (en) 2019-05-31 2020-12-03 Ccmar - Centro De Ciências Do Mar Universidade Do Algarve New endoperoxide compounds, process for obtaining them and uses thereof for control of perkinsiosis in bivalves
US20240101584A1 (en) * 2021-02-01 2024-03-28 Westlake University Targeted delivery of 1,2,4,5 tetraoxane compounds and their uses

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2901892A (en) * 1991-10-04 1993-05-03 Board Of Regents Of The University Of Nebraska, The Novel antimalarial peroxides and processes for their production and use
US6486199B1 (en) * 2001-06-21 2002-11-26 Medicines For Malaria Venture Mmv International Centre Cointrin Spiro and dispiro 1,2,4-trioxolane antimalarials
US6906098B2 (en) * 2002-02-09 2005-06-14 The United States Of America As Represented By The Secretary Of The Army Mixed steroidal 1,2,4,5-tetraoxane compounds and methods of making and using thereof
US6906205B2 (en) * 2002-06-21 2005-06-14 Medicines For Malaria Venture Mmv Spiro and dispiro 1,2,4-trioxolane antimalarials

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110452212A (zh) * 2019-07-30 2019-11-15 浙江大学 一种11-十一内酯类化合物和己内酯类化合物的制备方法
CN110452212B (zh) * 2019-07-30 2020-08-14 浙江大学 一种11-十一内酯类化合物和己内酯类化合物的制备方法

Also Published As

Publication number Publication date
EP2233479A1 (en) 2010-09-29
US20130023551A1 (en) 2013-01-24
GB0619333D0 (en) 2006-11-08
US20100113436A1 (en) 2010-05-06
JP2010505759A (ja) 2010-02-25
EP2091935A2 (en) 2009-08-26
WO2008038030A2 (en) 2008-04-03
CA2665339A1 (en) 2008-04-03
WO2008038030A3 (en) 2008-05-15

Similar Documents

Publication Publication Date Title
Li et al. Novel antitumor artemisinin derivatives targeting G1 phase of the cell cycle
Jung et al. Synthesis and antimalarial activity of (+)-deoxoartemisinin
Torok et al. Syntheses and antimalarial activities of N-substituted 11-azaartemisinins
EP1414813B1 (en) 1,2,4-trioxolane antimalarials
TWI507410B (zh) 新穎磷酸二酯酶抑制劑
EP2007769B1 (fr) Dimeres de derives d'artemisinine, leur préparation et leur application en thérapeutique
EP0167008B1 (de) 1,4:3,6-Dianhydro-hexit-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
AU2002327183A1 (en) 1,2,4-trioxolane antimalarials
CN101600703A (zh) 二螺四噁烷化合物及其在治疗疟疾和/或癌症中的应用
WO2011101774A1 (en) (r)-4-((4-((4-(tetrahydrofuran-3-yloxy)benzo[d]isoxazol-3-yloxy)methyl)piperidin-1-yl)methyl)tetrahydro-2h-pyran-4-ol, a partial agonist of 5-ht4 receptors
CN101631792B (zh) 新的磷酸二酯酶抑制剂
KR19980071530A (ko) 설폰아미드-치환된 크로만, 이의 제조방법, 약제 또는 진단 보조제로서의 이의 용도, 및 이를 포함하는 약제
TW200901979A (en) Compounds which have activity at M1receptor and their uses in medicine
US6136847A (en) Water-soluble trioxanes as potent and safe antimalarial agents
Bose et al. Synthesis, reactions and structure–activity relationships of 1-hydroxyspiro [2.5] cyclooct-4-en-3-ones: Illudin analogs with in vitro cytotoxic activity
CN111592520B (zh) 一类4,5-二取代基胡椒碱衍生物及其制备方法和应用
EP1687312B1 (fr) Molecules duales contenant un derive peroxydique, leur synthese et leurs applications therapeutiques
EP3209639B1 (en) Compounds as anti-malarials and their process of preparation
EP3418270A1 (en) Novel biphenylsulfoximines as allosteric modulators of the dopamine d1 receptor
Faist et al. Antiplasmodial and antitrypanosomal activity of bicyclic amides and esters of dialkylamino acids
US20050256184A1 (en) 1,2,4-Trioxanes and 1,2,4-trioxepanes
US10239836B2 (en) Benzenecarbothioccyclopenta[c] pyrrole-1,3-dione compounds and process for synthesis thereof
TWI432439B (zh) 新穎磷酸二酯酶抑制劑
WO2006070381A1 (en) Amino-functionalized 1,2,4-trioxanes useful as anti-malarial agents and process for preparation thereof
JPS59152386A (ja) 4,7−ジヒドロイソオキサゾロ〔5,4−b〕ピリジン誘導体およびその製造法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20091209